The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-12
DOI
10.3389/fpsyt.2021.623681
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
- (2020) Sophie E ter Hark et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
- (2020) Francky Teddy Endomba et al. Lipids in Health and Disease
- Metformin add‐on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial
- (2020) Christoph U. Correll et al. World Psychiatry
- Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs
- (2020) Nana Li et al. Frontiers in Pharmacology
- Central nervous pathways of insulin action in the control of metabolism and food intake
- (2020) Stephanie Kullmann et al. Lancet Diabetes & Endocrinology
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
- (2020) George A. Keepers et al. AMERICAN JOURNAL OF PSYCHIATRY
- Risk factors and pattern of weight gain in youths using antipsychotic drugs
- (2020) Casper C. L. van der Esch et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials
- (2019) Davy Vancampfort et al. World Psychiatry
- Leptin resistance: underlying mechanisms and diagnosis
- (2019) Olga Gruzdeva et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial
- (2019) Karsten Gjessing Jensen et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months
- (2019) Renate J. Schoemakers et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Metabolic Monitoring of Child and Adolescent Patients on Atypical Antipsychotics by Psychiatrists and Primary Care Providers
- (2019) Sarah Wakefield et al. AMERICAN JOURNAL OF THERAPEUTICS
- No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples
- (2019) Richard Border et al. AMERICAN JOURNAL OF PSYCHIATRY
- Adiposity, Hepatic Triglyceride, and Carotid Intima Media Thickness During Behavioral Weight Loss Treatment in Antipsychotic-Treated Youth: A Randomized Pilot Study
- (2019) Ginger E. Nicol et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Testing the role of genetic variation of the MC4R gene in Chinese population in antipsychotic-induced metabolic disturbance
- (2019) Yamin Zhang et al. Science China-Life Sciences
- The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
- (2019) Tali Bretler et al. BMC Medicine
- Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data
- (2019) Daniele Piovani et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis
- (2019) Błażej Misiak et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Reversibility of psychotropic medication induced weight gain among children and adolescents with bipolar disorders
- (2019) Navneet Upadhyay et al. PSYCHIATRY RESEARCH
- Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
- (2019) Wade Marteene et al. Expert Opinion On Drug Safety
- Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain
- (2019) Henrik Thyge Corfitsen et al. ACTA NEUROPSYCHIATRICA
- An up-to-date evaluation of lorcaserin hydrochloride for the treatment of obesity
- (2019) Beverly G. Tchang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans
- (2019) Malgorzata Maciukiewicz et al. SCHIZOPHRENIA RESEARCH
- Relationship of SNAP25 variants with schizophrenia and antipsychotic-induced weight change in large-scale schizophrenia patients
- (2019) Fanglin Guan et al. SCHIZOPHRENIA RESEARCH
- Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
- (2019) Diana Grajales et al. Cells
- Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives
- (2019) Paul Weihe et al. Current Obesity Reports
- Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: Results of a multicenter naturalistic study (ETAPE)
- (2019) Marie-Line Menard et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update
- (2018) Jennifer Pillay et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Safety of intranasal human insulin: A review
- (2018) Vera Schmid et al. DIABETES OBESITY & METABOLISM
- Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The relationship between gestational diabetes mellitus and selenoprotein-P plasma 1 (SEPP1) gene polymorphisms
- (2018) Gulhan Akbaba et al. GYNECOLOGICAL ENDOCRINOLOGY
- Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials
- (2018) Kah Kheng Goh et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study
- (2018) Jerome H. Taylor et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Obesity exacerbates the acute metabolic side effects of olanzapine
- (2018) Logan K. Townsend et al. PSYCHONEUROENDOCRINOLOGY
- The Gut Microbiome Profile in Obesity: A Systematic Review
- (2018) Olga Castaner et al. International Journal of Endocrinology
- Patterns of Early Mental Health Diagnosis and Medication Treatment in a Medicaid-Insured Birth Cohort
- (2018) Dinci Pennap et al. JAMA Pediatrics
- Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota
- (2018) Amy Chia-Ching Kao et al. Translational Psychiatry
- Antipsychotic Prescription in Children and Adolescents
- (2018) Christian J. Bachmann et al. Deutsches Arzteblatt International
- Glucagon-like peptide-1 receptor-agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis
- (2018) Dan Siskind et al. DIABETES OBESITY & METABOLISM
- Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain
- (2018) Malgorzata Maciukiewicz et al. JOURNAL OF NEURAL TRANSMISSION
- Childhood Obesity and Firmicutes/Bacteroidetes Ratio in the Gut Microbiota: A Systematic Review
- (2018) Cláudia Maria dos Santos Pereira Indiani et al. Childhood Obesity
- Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting
- (2018) Marco Pozzi et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- 23.4 Do Microbiome–Bile Acid Interactions Explain Antipsychotic-Induced Weight Gain?
- (2018) Erika L. Nurmi JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study
- (2018) Robert C. Smith et al. PSYCHOPHARMACOLOGY
- Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome
- (2018) Karolina Skonieczna-Żydecka et al. PSYCHOPHARMACOLOGY
- Do reductions in ghrelin contribute towards antipsychotic-induced weight gain?
- (2018) Joseph Firth et al. SCHIZOPHRENIA RESEARCH
- Meta-analysis of ghrelin alterations in schizophrenia: Effects of olanzapine
- (2018) Ryan L. Goetz et al. SCHIZOPHRENIA RESEARCH
- Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
- (2018) Dongyu Kang et al. Frontiers in Psychiatry
- Candidate gene associations studies in psychiatry: time to move forward
- (2017) C. Arango EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models
- (2017) Yayoi Kawata et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- International trends in antipsychotic use: A study in 16 countries, 2005–2014
- (2017) Óskar Hálfdánarson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Screening for Obesity and Intervention for Weight Management in Children and Adolescents
- (2017) Elizabeth A. O’Connor et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pediatric Antipsychotic Use and Outcomes Monitoring
- (2017) Paramala J. Santosh et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2017) Seyed-Ali Mostafavi et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Feasibility and Relevance of Antipsychotic Safety Monitoring in Children With Tourette Syndrome
- (2017) Tamara Pringsheim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association of expression of selenoprotein P in mRNA and protein levels with metabolic syndrome in subjects with cardiovascular disease: Results of the Selenegene study
- (2017) Mojgan Gharipour et al. JOURNAL OF GENE MEDICINE
- A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension
- (2017) Benjamin L. Handen et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus
- (2017) Mehmet Burcu et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Review of Childhood Obesity
- (2017) Seema Kumar et al. MAYO CLINIC PROCEEDINGS
- Selenoprotein P is elevated in individuals with obesity, but is not independently associated with insulin resistance
- (2017) Miaoxin Chen et al. Obesity Research & Clinical Practice
- Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
- (2017) Stephanie A. Flowers et al. PHARMACOTHERAPY
- Childhood Age and Associations Between Childhood Metabolic Syndrome and Adult Risk for Metabolic Syndrome, Type 2 Diabetes Mellitus and Carotid Intima Media Thickness: The International Childhood Cardiovascular Cohort Consortium
- (2017) Juha Koskinen et al. Journal of the American Heart Association
- Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study
- (2017) Francesca Borgo et al. Childhood Obesity
- Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
- (2017) Marco Solmi et al. Therapeutics and Clinical Risk Management
- Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
- (2017) Spyridon Siafis et al. Current Neuropharmacology
- Evidence-based recommendations for monitoring safety of second-generation antipsychotics in children and youth
- (2017) Tamara Pringsheim et al. Paediatrics & Child Health
- Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
- (2016) Peng Li et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study
- (2016) Inmaculada Baeza et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- An update on naltrexone/bupropion extended-release in the treatment of obesity
- (2016) Katherine H. Saunders et al. EXPERT OPINION ON PHARMACOTHERAPY
- Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls
- (2016) Hui Fang et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The role of melatonin and melatonin agonists in counteracting antipsychotic-induced metabolic side effects
- (2016) Hee Ryung Wang et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder
- (2016) Holland C. Detke et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Subjective Versus Objective Weight Gain During Acute Treatment With Second-Generation Antipsychotics in Schizophrenia and Bipolar Disorder
- (2016) Keming Gao et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review
- (2016) Christina Mangurian et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Betahistine decreases olanzapine-induced weight gain and somnolence in humans
- (2016) Nir Barak et al. JOURNAL OF PSYCHOPHARMACOLOGY
- BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment
- (2016) Stephen J Cooper et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Minireview: CNS Mechanisms of Leptin Action
- (2016) Jonathan N. Flak et al. MOLECULAR ENDOCRINOLOGY
- Sleep quality and obesity in young subjects: a meta-analysis
- (2016) Y. Fatima et al. Obesity Reviews
- Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications
- (2016) Jiamei Lian et al. PHARMACOLOGICAL RESEARCH
- Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis
- (2016) Brendon Stubbs et al. PSYCHONEUROENDOCRINOLOGY
- Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder
- (2016) Evdokia Anagnostou et al. JAMA Psychiatry
- The pharmacodynamic properties of lurasidone and their role in its antidepressant efficacy in bipolar disorder
- (2015) Konstantinos N. Fountoulakis et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Topiramate, zonisamide and weight loss in children and adolescents prescribed psychiatric medications
- (2015) Michael Shapiro et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
- Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism
- (2015) Hyeong-Kyu Park et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample
- (2015) E J Brandl et al. PHARMACOGENOMICS JOURNAL
- Clozapine and GABA transmission in schizophrenia disease models
- (2015) William T. O'Connor et al. PHARMACOLOGY & THERAPEUTICS
- Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D2 but not 5-HT2A/2C bindings in rat brains
- (2015) Jiamei Lian et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis
- (2015) Francesco Bartoli et al. PSYCHONEUROENDOCRINOLOGY
- Genome-Wide Association Study Suggested thePTPRDPolymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications
- (2015) Hao Yu et al. SCHIZOPHRENIA BULLETIN
- The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for its Methodology and a Review of the Effectiveness of Switching Antipsychotics
- (2015) S. Leucht et al. SCHIZOPHRENIA BULLETIN
- The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain
- (2015) Trehani M. Fonseka et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Leptin applications in 2015
- (2015) Olivia M. Farr et al. Current Opinion in Endocrinology Diabetes and Obesity
- Risk for Incident Diabetes Mellitus Following Initiation of Second-Generation Antipsychotics Among Medicaid-Enrolled Youths
- (2015) David M. Rubin et al. JAMA Pediatrics
- Use of the second-generation antipsychotic, risperidone and secondary weight gain are associated with an altered gut microbiota in children
- (2015) S M Bahr et al. Translational Psychiatry
- Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure
- (2015) Sarah M. Bahr et al. EBioMedicine
- Side effects of atypical antipsychotics: a brief overview
- (2015) ALP ÜÇOK et al. World Psychiatry
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- Recent international trends in psychotropic medication prescriptions for children and adolescents
- (2014) Hans-Christoph Steinhausen EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Weight gain and antipsychotics: a drug safety review
- (2014) Richard Musil et al. Expert Opinion On Drug Safety
- Atypical Antipsychotic Use Among Medicaid-Insured Children and Adolescents: Duration, Safety, and Monitoring Implications
- (2014) Mehmet Burcu et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Cardiometabolic Outcomes in Children and Adolescents Following Discontinuation of Long-Term Risperidone Treatment
- (2014) Chadi A. Calarge et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Melatonin, energy metabolism, and obesity: a review
- (2014) J. Cipolla-Neto et al. JOURNAL OF PINEAL RESEARCH
- Risk of Diabetes in Children and Adolescents Exposed to Antipsychotics: A Nationwide 12-Year Case-Control Study
- (2014) René Ernst Nielsen et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
- (2014) Jiamei Lian et al. PLoS One
- The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
- (2014) Andrew P. Morgan et al. PLoS One
- Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005
- (2014) Luuk J. Kalverdijk et al. PSYCHIATRIC SERVICES
- Pharmacogenetics of adverse events in schizophrenia treatment: Comparison study of ziprasidone, olanzapine and perazine
- (2014) Piotr Tybura et al. PSYCHIATRY RESEARCH
- Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways
- (2014) Jiamei Lian et al. PSYCHONEUROENDOCRINOLOGY
- Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
- (2014) Y. Mizuno et al. SCHIZOPHRENIA BULLETIN
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
- (2014) Paolo Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- Clozapine directly increases insulin and glucagon secretion from islets: Implications for impairment of glucose tolerance
- (2014) G.C. Smith et al. SCHIZOPHRENIA RESEARCH
- Molecular pathophysiology of metabolic effects of antipsychotic medications
- (2014) Jacob S. Ballon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Effects of metformin on weight loss
- (2014) Steven K. Malin et al. Current Opinion in Endocrinology Diabetes and Obesity
- Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders
- (2014) Christoph U. Correll et al. JAMA Psychiatry
- Leptin, GABA, and Glucose Control
- (2013) Barbara B. Kahn et al. Cell Metabolism
- Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease
- (2013) Karen L. Teff et al. DIABETES
- Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance
- (2013) M. O. Goodarzi et al. DIABETOLOGIA
- Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review
- (2013) José María Martínez-Ortega et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics
- (2013) Jacklyn N. Hellwege et al. GENE
- Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation
- (2013) Thomas M. Schilling et al. HUMAN BRAIN MAPPING
- MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?
- (2013) Fabian Czerwensky et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Twenty-Four Months of Antipsychotic Treatment in Children and Adolescents With First Psychotic Episode
- (2013) Ana Noguera et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia
- (2013) Weiping Yu et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia
- (2013) Jon McClellan et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- The genetic contribution of CIDEA polymorphisms, haplotypes and loci interaction to obesity in a Han Chinese population
- (2013) Jingjing Wu et al. MOLECULAR BIOLOGY REPORTS
- Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders
- (2013) Rasoul Ghasemi et al. MOLECULAR NEUROBIOLOGY
- Melatonin reduces body weight gain and increases nocturnal activity in male Wistar rats
- (2013) M.P. Terrón et al. PHYSIOLOGY & BEHAVIOR
- Association Study of Val66Met Polymorphism in Brain-Derived Neurotrophic Factor Gene with Clozapine-Induced Metabolic Syndrome: Preliminary Results
- (2013) Yi Zhang et al. PLoS One
- Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density
- (2013) Jiamei Lian et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics
- (2013) Ana Maria Volpato et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
- (2013) V. K. Ridaura et al. SCIENCE
- Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth
- (2013) William V. Bobo et al. JAMA Psychiatry
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
- (2013) E L Nurmi et al. Translational Psychiatry
- Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
- (2013) K J Davey et al. Translational Psychiatry
- Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain
- (2012) Anil K. Malhotra ARCHIVES OF GENERAL PSYCHIATRY
- National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics
- (2012) Mark Olfson et al. ARCHIVES OF GENERAL PSYCHIATRY
- Metabolic Screening in Children Receiving Antipsychotic Drug Treatment
- (2012) Elaine H. Morrato et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
- (2012) Bjørn H Ebdrup et al. BMC Medicine
- Role of leptin and adiponectin in insulin resistance
- (2012) Amita Yadav et al. CLINICA CHIMICA ACTA
- Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure
- (2012) Manuel Ferrer et al. ENVIRONMENTAL MICROBIOLOGY
- Comparison of Long-Term (At Least 24 Weeks) Weight Gain and Metabolic Changes Between Adolescents and Adults Treated with Olanzapine
- (2012) Ludmila A. Kryzhanovskaya et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Association of the Common MC4R rs17782313 Polymorphism With Antipsychotic-Related Weight Gain
- (2012) Fabian Czerwensky et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Rate of Weight Gain and Cardiometabolic Abnormalities in Children and Adolescents
- (2012) Chadi A. Calarge et al. JOURNAL OF PEDIATRICS
- Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model
- (2012) Chao Deng et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Automated design of ligands to polypharmacological profiles
- (2012) Jérémy Besnard et al. NATURE
- Human gut microbiome viewed across age and geography
- (2012) Tanya Yatsunenko et al. NATURE
- Intranasal Insulin Modulates Intrinsic Reward and Prefrontal Circuitry of the Human Brain in Lean Women
- (2012) Stephanie Kullmann et al. NEUROENDOCRINOLOGY
- Antipsychotics for Children and Young Adults: A Comparative Effectiveness Review
- (2012) J. C. Seida et al. PEDIATRICS
- Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
- (2012) N I Chowdhury et al. PHARMACOGENOMICS JOURNAL
- Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain
- (2012) E.J. Brandl et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain
- (2012) Gwyneth C.M. Zai et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Antipsychotic Use by Medicaid-Insured Youths: Impact of Eligibility and Psychiatric Diagnosis Across a Decade
- (2012) Julie Magno Zito et al. PSYCHIATRIC SERVICES
- Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination
- (2012) Michael Poyurovsky et al. PSYCHOPHARMACOLOGY
- Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
- (2012) Kieran J. Davey et al. PSYCHOPHARMACOLOGY
- Weight Gain and Metabolic Syndrome Among Young Patients on Antipsychotic Medication: What do we Know and Where do we go?
- (2011) Valsamma Eapen et al. Australasian Psychiatry
- Atypical Antipsychotic-Induced Weight Gain
- (2011) James L. Roerig et al. CNS DRUGS
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
- (2011) M. De Hert et al. EUROPEAN PSYCHIATRY
- Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain
- (2011) Vincenzo De Luca et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain
- (2011) Young-Min Park et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- The Pharmacoepidemiology of Antipsychotic Medications for Canadian Children and Adolescents: 2005–2009
- (2011) Tamara Pringsheim et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
- (2011) Lawrence Maayan et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Double-Blind Maintenance Safety and Effectiveness Findings From the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) Study
- (2011) Robert L. Findling et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
- (2011) T A P Lett et al. MOLECULAR PSYCHIATRY
- Unravelling the effects of the environment and host genotype on the gut microbiome
- (2011) Aymé Spor et al. NATURE REVIEWS MICROBIOLOGY
- Association Study of Brain-Derived Neurotrophic Factor Gene Polymorphisms and Body Weight Change in Schizophrenic Patients Under Long-Term Atypical Antipsychotic Treatment
- (2011) Ashley Tsai et al. NEUROMOLECULAR MEDICINE
- Responses of Gut Microbiota to Diet Composition and Weight Loss in Lean and Obese Mice
- (2011) Yann Ravussin et al. Obesity
- The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese children
- (2011) Lingling Gao et al. PEDIATRIC DIABETES
- Antipsychotic Medication Use Among Children and Risk of Diabetes Mellitus
- (2011) S. E. Andrade et al. PEDIATRICS
- Increasing off-label use of antipsychotic medications in the United States, 1995-2008
- (2011) G. C. Alexander et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications
- (2011) Amy K Lee et al. PHARMACOGENOMICS
- Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting
- (2011) Jochem G Gregoor et al. PHARMACOGENOMICS
- Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus
- (2011) Ling Shen et al. PHYSIOLOGY & BEHAVIOR
- Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism
- (2011) Karen L. Teff et al. PHYSIOLOGY & BEHAVIOR
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
- (2011) Alex J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: A population-based study
- (2011) Chun-Hui Liao et al. SCHIZOPHRENIA RESEARCH
- Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: An animal model
- (2011) Margaret Hahn et al. SCHIZOPHRENIA RESEARCH
- iPHACE: integrative navigation in pharmacological space
- (2010) Ricard Garcia-Serna et al. BIOINFORMATICS
- The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats
- (2010) Martina von Wilmsdorff et al. Clinics
- Association of the cell death-inducing DNA fragmentation factor alpha-like effector A (CIDEA) gene V115F (G/T) polymorphism with phenotypes of metabolic syndrome in a Chinese population
- (2010) Ling Zhang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies
- (2010) Konstantinos C M Siontis et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
- (2010) C.U. Correll EUROPEAN PSYCHIATRY
- Management of antipsychotic-related weight gain
- (2010) Lawrence Maayan et al. Expert Review of Neurotherapeutics
- Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients
- (2010) Arun K. Tiwari et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Association Between the 1291-C/G Polymorphism in the Adrenergic α-2a Receptor and the Metabolic Syndrome
- (2010) Arne J. Risselada et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Endocannabinoid Pro129Thr FAAH Functional Polymorphism But Not 1359G/A CNR1 Polymorphism Is Associated With Antipsychotic-Induced Weight Gain
- (2010) Palmiero Monteleone et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Serotonin and Melanocortin Circuit Mediates D-Fenfluramine Anorexia
- (2010) Y. Xu et al. JOURNAL OF NEUROSCIENCE
- A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia
- (2010) Arun K Tiwari et al. NEUROPSYCHOPHARMACOLOGY
- Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
- (2010) Lawrence Maayan et al. NEUROPSYCHOPHARMACOLOGY
- Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment
- (2010) Chen-Jee Hong et al. Pharmacogenetics and Genomics
- DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia
- (2010) Todd Lencz et al. Pharmacogenetics and Genomics
- Association ofHTR2C, but notLEPorINSIG2, genes with antipsychotic-induced weight gain in a German sample
- (2010) Carolin Opgen-Rhein et al. PHARMACOGENOMICS
- Polymorphisms of theHTR2Cgene and antipsychotic-induced weight gain: an update and meta-analysis
- (2010) Michelle N Sicard et al. PHARMACOGENOMICS
- Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
- (2010) D J Müller et al. PHARMACOGENOMICS JOURNAL
- Gene–gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics
- (2010) Y-J Liou et al. PHARMACOGENOMICS JOURNAL
- Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia
- (2010) M R Kuzman et al. PHARMACOGENOMICS JOURNAL
- Association between LEP and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication
- (2010) Jochem G. Gregoor et al. PSYCHIATRIC GENETICS
- Antipsychotic drugs and obesity
- (2010) Christoph U. Correll et al. TRENDS IN MOLECULAR MEDICINE
- Contribution of leptin to the formation of neuroleptic obesity in patients with schizophrenia during antipsychotic therapy
- (2009) L. N. Gorobets BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
- (2009) Mario Álvarez-Jiménez et al. CNS DRUGS
- Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges
- (2009) Stephen Crystal et al. HEALTH AFFAIRS
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents
- (2009) Chadi A. Calarge et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Metformin for Weight Control in Pediatric Patients on Atypical Antipsychotic Medication
- (2009) Lauren Shin et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study
- (2009) S. Gebhardt et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Metabolic and Hormonal Side Effects in Children and Adolescents Treated With Second-Generation Antipsychotics
- (2009) David Fraguas et al. JOURNAL OF CLINICAL PSYCHIATRY
- Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent?
- (2009) Viktoria Simon et al. JOURNAL OF CLINICAL PSYCHIATRY
- Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents
- (2009) Sun H. Kim et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Bias in genetic association studies and impact factor
- (2009) M R Munafò et al. MOLECULAR PSYCHIATRY
- Association of the α2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European–Americans
- (2009) Laertes Sickert et al. PHARMACOGENOMICS
- Sex-specific differences in side effects of psychotropic drugs: genes or gender?
- (2009) Sara Haack et al. PHARMACOGENOMICS
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
- (2008) Linmarie Sikich et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotics and Diabetes: An Age-Related Association
- (2008) Ariel Hammerman et al. ANNALS OF PHARMACOTHERAPY
- Adolescent Obesity and Puberty: The “Perfect Storm”
- (2008) Carolyn Bradner Jasik et al. Annals of the New York Academy of Sciences
- Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents
- (2008) Roger S. McIntyre et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia
- (2008) Olga O. Yevtushenko et al. BRITISH JOURNAL OF PSYCHIATRY
- Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut Microbiome
- (2008) Peter J. Turnbaugh et al. Cell Host & Microbe
- Transcriptional Regulation of HMG-CoA Synthase and HMG-CoA Reductase Genes by Human ACBP
- (2008) Christina Vock et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia
- (2008) Marilyn Ader et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course
- (2008) Stefan Gebhardt et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
- (2008) S Le Hellard et al. MOLECULAR PSYCHIATRY
- A core gut microbiome in obese and lean twins
- (2008) Peter J. Turnbaugh et al. NATURE
- Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom
- (2008) F. Rani et al. PEDIATRICS
- Psychotropic Medication Patterns Among Youth in Foster Care
- (2008) J. M. Zito et al. PEDIATRICS
- The influence of 5-HT2C and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients
- (2008) Martina Rojnic Kuzman et al. PSYCHIATRY RESEARCH
- Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin
- (2008) Hua Jin et al. SCHIZOPHRENIA RESEARCH
- An investigation of theα1A-adrenergic receptor gene and antipsychotic-induced side-effects
- (2007) Pilar A. Saiz et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Possible association between the −2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain
- (2007) Seung-Gul Kang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
- (2007) O. Sentissi et al. SCHIZOPHRENIA BULLETIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now